Navigation Links
AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
Date:8/11/2009

All amounts are in U.S. dollars

QUEBEC CITY, Aug. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) ("the Company"), a global biopharmaceutical company focused on endocrinology and oncology, today reported financial and operating results as at and for the three-month and six-month periods ended June 30, 2009.

    Second Quarter 2009 Highlights

    April

    - Two poster presentations at the American Association of Cancer
      Research ("AACR") Annual Meeting on in vitro and in vivo results for
      AEZS-126 in human tumors, and one poster presentation on Phase 1
      results with AEZS-112 in solid tumors or lymphoma.

    - Notification from Nasdaq that the Company had regained compliance
      with Nasdaq's minimum bid price rules.

    May

    - Presentation at the American Society of Clinical Oncology ("ASCO")
      Annual Meeting of results supporting evaluation of AEZS-108 in
      prostate cancer.

    June

    - Presentation at the ASCO Annual Meeting of positive Phase 2 data on
      perifosine in advanced metastatic colon cancer and advanced renal cell
      carcinoma by the Company's partner, Keryx Biopharmaceuticals, Inc.

    - Acquisition from Ardana Bioscience Ltd. of all assets relating to
      AEZS-130.

    - Disclosure of neutral results for the Company's Phase 2 trial in
      non-small cell lung cancer with perifosine as radioenhancer.

    - Announcement of the initiation of the extension of the Company's North
      American Phase 3 efficacy study with cetrorelix in benign prostatic
      hyperplasia ("BPH"). This extension of the study is sponsored by
      sanofi-aventis, the Company's partner for the US market.

    - Poster presentation at the Endocrine Society ("ENDO") Annual Meeting
      on AEZS-130 as a simple diagnostic test for 
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/24/2014)... NEW YORK , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, ... in critical areas, announced the closing of an underwritten public ... purchase up to an aggregate 3,500,000 shares of common stock, ... per warrant.  The warrants have a per share exercise price ...
(Date:12/24/2014)... 2014 GMO corn cases filed across the ... the process of being consolidated in a Kansas federal court ... AG MIR 162 Corn Litigation, MDL No. 2591 in the ... of the Syngenta GMO corn multidistrict litigation (MDL) has been ...
(Date:12/24/2014)... Long Island, New York (PRWEB) December 23, 2014 ... , and the Long Island Affiliate of ITRA Global, the ... economy’s slow but steady recovery. This is evidenced by ... and the strong stock market. Low energy costs have ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3
... , ... , Chairman of Tech Coast Angels (TCA), the nation,s largest ... program of increased entrepreneur support, communication and mentoring will be overseen by ... constrained economy, entrepreneurs need easier access to viable sources of help and ...
... , Jan. 26 Medical & ... Osaka University, has successfully generated several fully human monoclonal ... by utilizing blood samples from volunteers who were inoculated with ... at the Department of Virology, Research Institute for Microbial Diseases, ...
... , TUALATIN, Ore. , Jan. 26 ... company dedicated to the acquisition, development, and commercialization of ... an agreement with British-based Ingenion Design Ltd. ("Ingenion") to ... Measurement Device (GasPT2). , The GasPT2, designed by GL ...
Cached Biology Technology:Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 2Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 3Sudek of Tech Coast Angels Announces Network's Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs 4Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner 2Generation of Fully Human Monoclonal Antibodies Neutralizing Influenza Virus - Use of SPYMEG as a novel human lymphocyte fusion partner 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 2Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 3Waytronx Announces Agreement for Development and Production of Its GASPT2 Device With UK-Based Ingenion Design Limited 4
(Date:12/17/2014)... 15, 2014 Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ... Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology ... http://photos.prnewswire.com/prnh/20130307/600769 Based on a ... introduces for the first time a fingerprint sensor in ...
(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
(Date:12/11/2014)... PAUL, Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... The Institute for Research in Biomedicine (IRB Barcelona) has ... two European health research projects, as part of the ... makes IRB Barcelona a leader in European projects in ... all, Spanish centres will be heading ten projects. The ...
... think twice about spending money on a commercial flame ... your tree in a container of fresh wateris probably ... healthy. Researchers have determined that some flame retardants don,t ... cases the chemical retardants sped up the drying process ...
... say "shade grown, please" when you order your morning ... under a canopy of multiple tree species, not only ... also maintain genetic diversity of native tree species and ... The finding comes from a study published by ...
Cached Biology News:IRB Barcelona to coordinate two European projects on biomedicine 2IRB Barcelona to coordinate two European projects on biomedicine 3Flame retardants prove ineffective on fresh-cut Christmas trees 2Shade coffee benefits more than birds 2Shade coffee benefits more than birds 3
Mouse/Rat WNK1 Affinity Purified Polyclonal Ab...
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
... The SYBR Safe photographic filter ... Gels and Blots) is ideal for ... the SYBR Safe DNA gel stain, ... that the SYBR Safe photographic filter ...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Biology Products: